DekaBank Deutsche Girozentrale
ITCI

DekaBank Deutsche Girozentrale’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$4.09M Hold
51,997
0.01% 607
2025
Q1
$6.74M Hold
51,997
0.01% 510
2024
Q4
$4.32M Hold
51,997
0.01% 600
2024
Q3
$3.8M Sell
51,997
-502
-1% -$36.7K 0.01% 641
2024
Q2
$3.71M Buy
52,499
+502
+1% +$35.5K 0.01% 637
2024
Q1
$3.59M Hold
51,997
0.01% 652
2023
Q4
$3.79M Buy
51,997
+11,000
+27% +$802K 0.01% 640
2023
Q3
$2.19M Buy
40,997
+997
+2% +$53.3K 0.01% 716
2023
Q2
$2.46M Buy
40,000
+5,000
+14% +$308K 0.01% 706
2023
Q1
$1.93M Hold
35,000
﹤0.01% 730
2022
Q4
$1.85M Sell
35,000
-8,219
-19% -$433K ﹤0.01% 734
2022
Q3
$1.93M Sell
43,219
-364
-0.8% -$16.2K 0.01% 714
2022
Q2
$2.48M Sell
43,583
-917
-2% -$52.2K 0.01% 679
2022
Q1
$2.72M Buy
44,500
+12,700
+40% +$775K 0.01% 689
2021
Q4
$1.63M Buy
31,800
+900
+3% +$46K ﹤0.01% 820
2021
Q3
$1.1M Hold
30,900
﹤0.01% 880
2021
Q2
$1.21M Hold
30,900
﹤0.01% 867
2021
Q1
$993K Hold
30,900
﹤0.01% 904
2020
Q4
$953K Sell
30,900
-1,500
-5% -$46.3K ﹤0.01% 881
2020
Q3
$811K Buy
+32,400
New +$811K ﹤0.01% 827
2019
Q4
Sell
-65,700
Closed -$493K 1233
2019
Q3
$493K Sell
65,700
-65,700
-50% -$493K ﹤0.01% 774
2019
Q2
$1.67M Buy
131,400
+42,500
+48% +$540K 0.01% 667
2019
Q1
$1.95M Buy
88,900
+9,200
+12% +$201K 0.01% 615
2018
Q4
$868K Sell
79,700
-9,200
-10% -$100K 0.01% 716
2018
Q3
$1.95M Buy
88,900
+12,700
+17% +$278K 0.01% 628
2018
Q2
$1.36M Sell
76,200
-137,000
-64% -$2.44M 0.01% 681
2018
Q1
$4.39M Sell
213,200
-76,000
-26% -$1.56M 0.03% 418
2017
Q4
$3.35M Hold
289,200
0.03% 454
2017
Q3
$3.35M Hold
289,200
0.03% 459
2017
Q2
$3.67M Buy
289,200
+50,000
+21% +$634K 0.03% 437
2017
Q1
$3.89M Buy
239,200
+229,200
+2,292% +$3.73M 0.04% 386
2016
Q4
$155K Buy
+10,000
New +$155K ﹤0.01% 863
2016
Q3
Sell
-76,000
Closed -$2.85M 1034
2016
Q2
$2.85M Buy
+76,000
New +$2.85M 0.03% 404